Search Medical Condition
Please enter condition
Please choose location

Bloomsbury, United Kingdom Clinical Trials

A listing of Bloomsbury, United Kingdom clinical trials actively recruiting patients volunteers.

RESULTS

Found (556) clinical trials

Genes and Other Risk Factors for Second Primary Breast Cancer in Women With Breast Cancer and Their Female Family Members and Friends

OBJECTIVES: - To identify new breast cancer susceptibility alleles in breast cancer patients and family controls. - To compare the prevalence of known polymorphisms in genes involved in hormonal activation and degradation pathways in breast cancer patients and family controls. - To correlate these polymorphisms with quantitative intermediate markers of ...

Phase N/A

0.14 miles

Learn More »

LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab

In this phase I, open-label, multi-arm, multicentre, multi-dose dose escalation study in patients with transdermally accessible tumours; the safety, PK and efficacy of different dosing regimens of LTX-315 will be assessed. Patients will be allocated into 4 separate (parallel) arms depending on the tumour type and the number of lesions ...

Phase

0.21 miles

Learn More »

This clinical trial is provided by Antidote. Better memory

Phase

0.25 miles

Learn More »

Dominantly Inherited Alzheimer Network (DIAN)

Dominantly inherited Alzheimer's disease (AD) represents less than 1% of all cases of AD and is an important model for study because the responsible mutations have known biochemical consequences that are believed to underlie the pathological basis of the disorder. Three major hypotheses will be tested: - First, that there ...

Phase N/A

0.25 miles

Learn More »

A Multicenter Multinational Observational Morquio A Registry Study (MARS)

MARS is a multicenter, multinational, observational disease registry for patients diagnosed with Mucopolysaccharidosis Type IVA (MPS IVA). The Registry will collect medical history, and clinical and safety assessments every six months, for up to 10 years. The Registry will enroll and collect data on patients over a period of at ...

Phase N/A

0.25 miles

Learn More »